Cornerstone Therapeutics Inc. · Cary, NC United States (NASDAQ: CRTX)
| 1255 Crescent Green Dr., Ste. 250 | Phone: 919-678-6611 |
| Cary, NC | Fax: 866-443-3092 |
| 27518 | |
| United States | 
Map This Company |
Cornerstone Therapeutics Inc. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Cornerstone Therapeutics wants to help clear things up for the asthmatic, the infected, and the inflamed. The drug company is focused on developing and commercializing therapeutic products to prevent and treat acute inflammation and other respiratory ailments. Its marketed products include CUROSURF, which is used to treat premature infants with respiratory distress syndrome, antibiotics FACTIVE and SPECTRACEF, and asthma treatment ZYFLO. It also is developing generic drugs through its Aristos Pharmaceuticals subsidiary. The company relies up on third parties to manufacture its marketed products and products in clinical trials. Italian drugmaker Chiesi Farmaceutici owns a majority stake in the company.
Cornerstone Therapeutics Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: CRTX Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 147 |
Executives
14 executives listed for Cornerstone Therapeutics Inc.'s Cary, NC location.
| Chairman, President, and CEO | Craig Collard | |
|---|---|---|
| EVP Finance and CFO | Vincent Morgus | |
| EVP, General Counsel, and Secretary | Andrew Powell |